Dr. David A. Fox

Dr. J. Michelle Kahlenberg MD, PhD is a physician scientist and Associate Professor of Internal Medicine at the University of Michigan. She completed her MD, PhD, and Internal Medicine training at Case Western Reserve University and completed her fellowship in Rheumatology at the University of Michigan. She joined the University of Michigan faculty in 2011, was appointed Assistant Professor in 2012, and was promoted to Associate Professor with tenure in 2018. She has been running her own laboratory and has been an active member of the Immunology Training Program since 2013. Her clinical work is centered on the care of complicated lupus patients, including those with refractory skin disease. Her R01-funded research laboratory combines translational approaches using patient samples and murine models to uncover the mechanisms that drive lupus and lupus flares. In particular, she is focused on unraveling the pathogenic mechanisms in cutaneous lupus, the factors that drive photosensitivity, and how skin inflammation can influence systemic lupus activity. Her work has received institutional accolades and national recognition from the Arthritis National Research Foundation, The Rheumatology Research Foundation, American Society for Clinical Investigation and the Lupus Foundation of America. In her spare time, she enjoys organic gardening, working on the family farm EMMA Acres run by her husband, Mark, and spending time with her husband and children. Dr. Kahlenberg is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus (SLE), Dermatomyositis, and Mevalonate Kinase Deficiency. Dr. Kahlenberg is board certified in Rheumatology. Dr. Kahlenberg is currently accepting new patients.

John Varga is a Rheumatologist practicing medicine in Ann Arbor, Michigan. Dr. Varga is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Localized Scleroderma. Dr. Varga is board certified in Rheumatology and Internal Medicine. Dr. Varga is currently accepting new patients.

Dr. Knight received his M.D. and Ph.D. degrees from the University of Michigan and completed his molecular biology Ph.D. research in the laboratory of Dr. Erle Robertson at the University of Pennsylvania. His fellowship in rheumatology was at the University of Michigan, where he pursued postdoctoral research in the laboratory of Dr. Mariana Kaplan. During fellowship, he received the prestigious American College of Rheumatology Distinguished Fellow Award, as well as a Rheumatology Research Foundation Scientist Development Award.As a faculty member, he has been awarded the Jerome W. Conn Award for Excellence in Research by the Department of Internal Medicine. He has also received the Edmund L. Dubois Award for young lupus researchers from the American College of Rheumatology and the Mary Betty Stevens Young Investigator Prize from the Lupus Foundation of America. He is a member of the American Society for Clinical Investigation.His NIH-funded research laboratory has also received financial support from the Burroughs Wellcome Fund, Department of Defense, Lupus Research Alliance, and Rheumatology Research Foundation, His research group is working to better understand the triggers and effectors of autoimmunity in lupus and the related antiphospholipid syndrome (APS). His group is also interested in other diseases characterized by excessive neutrophil-mediated inflammation including diabetes and COVID-19.Dr. Knight is an international leader in the clinical care of APS patients and the role of inflammation in APS. Contact Dr. Knight if you are interested in participating in APS research studies. Dr. Knight is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Antiphospholipid Syndrome, Systemic Lupus Erythematosus (SLE), Takayasu Arteritis, and Granulomatosis with Polyangiitis. Dr. Knight is board certified in Rheumatology. Dr. Knight is currently accepting new patients.